Arjuna Therapeutics — Seed · €1.5M

Arjuna Therapeutics is a University of Santiago de Compostela spin-out developing Therapeutic Molecular Clusters, led by Ag5, against pancreatic cancer and glioblastoma. It closed a €1.5M round through an equity crowdfunding campaign on Capital Cell, reaching 125% of its target; parent company Nanogap and specialist investors from the UK and Silicon Valley also took part.